KUALA LUMPUR: Pharmaniaga Bhd
said its strategic plan and initiatives "have put the group on the right track of recovery,” with its profit after tax (PAT) increasing to RM30.0 million for the first half of 2024, up from RM5.1 million in the same period last year.
The group also reported a 4.3 per cent increase in revenue to RM1.8 billion, driven by higher demand in the concession and Indonesia segments.
Its earnings before interest, taxation, depreciation, and amortisation grew by 53.5 per cent to RM97.8 million, while profit before zakat and taxation (PBT) surged by 172.8 per cent to RM42.4 million from RM15.5 million, the company said in a statement.
For the second quarter, Pharmaniaga’s PAT increased by 65.5 per cent to RM3.8 million from RM2.3 million the previous year, while revenue dipped 1.2 per cent to RM838.3 million. - Bernama
